COHANCE
Invest with MTF
Invest Now
Invest in Cohance Lifesciences with 2.86X leverage
Performance
- Low
- ₹533
- High
- ₹538
- 52 Week Low
- ₹518
- 52 Week High
- ₹1,328
- Open Price₹536
- Previous Close₹536
- Volume296,242
Investment Returns
- Over 1 Month -6.5%
- Over 3 Month -38.19%
- Over 6 Month -43.08%
- Over 1 Year -53.98%
Smart Investing Starts Here Start SIP with Cohance Lifesciences for Steady Growth!
Cohance Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 82.9
- PEG Ratio
- 42.5
- Market Cap Cr
- 20,557
- P/B Ratio
- 5.4
- Average True Range
- 15.21
- EPS
- 8.98
- Dividend Yield
- 0
- MACD Signal
- -37.66
- RSI
- 32.67
- MFI
- 50.84
Cohance Lifesciences Financials
Cohance Lifesciences Technicals
EMA & SMA
Current Price
₹537.35
+
1.15
(0.21%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹551.63
- 50 Day
- ₹635.87
- 100 Day
- ₹745.84
- 200 Day
- ₹856.69
Resistance and Support
536.33
- R3 544.42
- R2 541.38
- R1 539.37
- S1 534.32
- S2 531.28
- S3 529.27
Cohance Lifesciences Corporate Actions - Bonus, Splits, Dividends
Cohance Lifesciences F&O
About Cohance Lifesciences
- NSE Symbol
- COHANCE
- BSE Symbol
- 543064
- Managing Director
- Dr. V Prasada Raju
- ISIN
- INE03QK01018
Similar Stocks to Cohance Lifesciences
Cohance Lifesciences FAQs
Cohance Lifesciences share price is ₹537 As on 28 December, 2025 | 16:43
The Market Cap of Cohance Lifesciences is ₹20557.2 Cr As on 28 December, 2025 | 16:43
The P/E ratio of Cohance Lifesciences is 82.9 As on 28 December, 2025 | 16:43
The PB ratio of Cohance Lifesciences is 5.4 As on 28 December, 2025 | 16:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.